Phase I study of mRNA 1850

Trial Profile

Phase I study of mRNA 1850

Planning
Phase of Trial: Phase I

Latest Information Update: 15 Jan 2016

At a glance

  • Drugs MRNA 1850 (Primary)
  • Indications Bacterial infections; Parasitic infections; Viral infections
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 15 Jan 2016 New trial record
    • 12 Jan 2016 According to Moderna Therapeutics media release, company is planning to initiate this trial in the first quarter of 2016 and the company has also filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for mRNA 1850.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top